Patent · US Active

ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors

US7897623B2 · kind B2 · utility

26Cited by

242References

8Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Bernd Riedl · Wuppertal, DE
Jacques Dumas · Neuilly-Plaisance, FR
Uday Khire · Hamden, US
Timothy B. Lowinger · Carlisle, US
William Scott · Guilford, US
Roger Smith · Madison, US
Jill Wood · Hampton, US
Mary-Katherine Monahan · Hamden, US
Reina Natero · Hamden, US
Joel Renick · San Diego, US
Robert Sibley · North Haven, US

Key dates

Filing date	Aug 27, 2007
Grant date	Mar 1, 2011
Priority date	—
Expiry date	Aug 22, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.